A detailed history of Highland Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Highland Capital Management, LLC holds 66,145 shares of BMY stock, worth $3.57 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
66,145
Previous 71,689 7.73%
Holding current value
$3.57 Million
Previous $3.89 Million 29.33%
% of portfolio
0.16%
Previous 0.22%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$40.25 - $52.99 $223,146 - $293,776
-5,544 Reduced 7.73%
66,145 $2.75 Million
Q1 2024

May 07, 2024

SELL
$47.98 - $54.4 $35,601 - $40,364
-742 Reduced 1.02%
71,689 $3.89 Million
Q4 2023

Jan 17, 2024

BUY
$48.48 - $57.85 $10,908 - $13,016
225 Added 0.31%
72,431 $3.72 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $325,631 - $364,106
-5,625 Reduced 7.23%
72,206 $4.19 Million
Q2 2023

Aug 09, 2023

SELL
$63.71 - $70.74 $73,585 - $81,704
-1,155 Reduced 1.46%
77,831 $4.98 Million
Q1 2023

May 11, 2023

SELL
$65.71 - $74.53 $34,169 - $38,755
-520 Reduced 0.65%
78,986 $5.47 Million
Q4 2022

Feb 07, 2023

SELL
$68.48 - $81.09 $27,392 - $32,436
-400 Reduced 0.5%
79,506 $5.72 Million
Q3 2022

Nov 09, 2022

SELL
$0.13 - $76.84 $474 - $280,466
-3,650 Reduced 4.37%
79,906 $5.68 Million
Q2 2022

Jul 14, 2022

BUY
$72.62 - $79.98 $226,574 - $249,537
3,120 Added 3.88%
83,556 $6.43 Million
Q1 2022

Apr 19, 2022

BUY
$61.48 - $73.72 $111,278 - $133,433
1,810 Added 2.3%
80,436 $5.87 Million
Q4 2021

Jan 28, 2022

SELL
$53.63 - $62.52 $58,993 - $68,772
-1,100 Reduced 1.38%
78,626 $4.9 Million
Q3 2021

Oct 25, 2021

SELL
$59.17 - $69.31 $184,018 - $215,554
-3,110 Reduced 3.75%
79,726 $4.72 Million
Q2 2021

Jul 30, 2021

SELL
$61.91 - $67.42 $2.63 Million - $2.86 Million
-42,480 Reduced 33.9%
82,836 $5.54 Million
Q1 2021

Apr 27, 2021

BUY
$59.34 - $66.74 $1.89 Million - $2.13 Million
31,844 Added 34.07%
125,316 $7.91 Million
Q4 2020

Jan 21, 2021

SELL
$57.74 - $65.43 $2.08 Million - $2.36 Million
-36,099 Reduced 27.86%
93,472 $5.8 Million
Q3 2020

Oct 16, 2020

SELL
$57.43 - $63.64 $93,955 - $104,115
-1,636 Reduced 1.25%
129,571 $7.81 Million
Q2 2020

Jul 22, 2020

BUY
$54.82 - $64.09 $538,606 - $629,684
9,825 Added 8.09%
131,207 $7.72 Million
Q1 2020

May 05, 2020

SELL
$46.4 - $67.43 $827,033 - $1.2 Million
-17,824 Reduced 12.8%
121,382 $6.77 Million
Q4 2019

Feb 05, 2020

BUY
$49.21 - $64.19 $1.7 Million - $2.22 Million
34,624 Added 33.11%
139,206 $8.94 Million
Q3 2019

Nov 20, 2019

BUY
$42.77 - $50.71 $4.47 Million - $5.3 Million
104,582 New
104,582 $5.3 Million
Q4 2018

Jan 16, 2019

SELL
$48.76 - $63.23 $1.12 Million - $1.45 Million
-22,964 Closed
0 $0
Q3 2018

Oct 17, 2018

BUY
$55.19 - $62.25 $609,407 - $687,364
11,042 Added 92.62%
22,964 $1.43 Million
Q2 2018

Jul 18, 2018

SELL
$50.53 - $62.98 $7,579 - $9,447
-150 Reduced 1.24%
11,922 $660,000
Q1 2018

Apr 16, 2018

BUY
$59.92 - $68.98 $96,471 - $111,057
1,610 Added 15.39%
12,072 $764,000
Q4 2017

Jan 26, 2018

BUY
$59.94 - $65.35 $21,938 - $23,918
366 Added 3.63%
10,462 $641,000
Q3 2017

Oct 10, 2017

BUY
$55.23 - $63.74 $557,602 - $643,519
10,096
10,096 $644,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Highland Capital Management, LLC Portfolio

Follow Highland Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management, LLC with notifications on news.